Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tradipitant for GLP-1R agonist-induced nausea and vomiting
NCT06804603Phase 2Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Feb 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tradipitant, sponsored by Vanda Pharmaceuticals Inc.. Started Feb 2025; status: completed.
02
Drugs
tradipitant
Beyond the preview
Go deeper on NCT06804603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06804603.